Denali Therapeutics

DNLI · NASDAQ

$18.93+$0.89 (+4.93%)TodayMarket closed ·
Prev close $18.04

Who owns DNLI

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 49.9% of DNLI’s shares.

  • T. Rowe Price Investment Management, Inc.10.2%
  • Baillie Gifford & Co.7.5%
  • BlackRock Institutional Trust Company, N.A.7.4%
  • State Street Investment Management (US)4.4%
  • Next 6 largest institutions20.3%
  • All other shareholders50.1%
Top institutional holders of DNLI
HolderShares% of shares
T. Rowe Price Investment Management, Inc.16.18M10.19%
Baillie Gifford & Co.11.96M7.54%
BlackRock Institutional Trust Company, N.A.11.81M7.44%
State Street Investment Management (US)7.05M4.44%
Temasek Holdings Pte. Ltd.7.01M4.42%
Vanguard Portfolio Management, LLC6.48M4.08%
Vanguard Capital Management, LLC6.28M3.95%
Fidelity Management & Research Company LLC4.54M2.86%
Geode Capital Management, L.L.C.3.97M2.50%
Holocene Advisors, LP3.91M2.46%

Largest mutual fund holders

Top mutual fund holders of DNLI
HolderShares% of shares
Scottish Mortgage Investment Trust PLC7.04M4.44%
T. Rowe Price Capital Appreciation Fund4.97M3.13%
Vanguard Total Stock Market Index Fund4.31M2.72%
iShares Russell 2000 ETF3.82M2.40%
State Street SPDR S&P Biotech ETF3.66M2.30%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $435.30K (5 trades) of DNLI on the open market, with no buys.

Latest DNLI insider transactions
InsiderTypeSharesValue
Chin Peter ScottSale1.65K$36.87K
Thornberry NancySale615$14.60K
Thornberry NancySale10.82K$247.33K
Schuth Alexander O.Sale2.77K$64.88K
Watts Ryan J.Gift32.22K—
Schuth Alexander O.Sale2.86K$71.62K
Van Hauwermeiren TimothyAward19.23K—
Van Hauwermeiren TimothyAward6.41K—
Thornberry NancyAward19.23K—
Thornberry NancyAward6.41K—

Short interest

Settled Sep 30, 2026

Shares short
15.46M
Days to cover
7.64
% of shares outstanding
9.74%
Average daily volume
2.02M
Change since last report
−9.8%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.